Filtered by:
20 Programs
-
Second Opinion
Optimal Management of Localized Renal Cell Carcinoma
-
-
E
-
T
-
U
-
E
-
-
Oncology Today
Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer
-
-
W
-
W
-
-
W
-
W
-
-
Year in Review
Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer
-
-
A
-
S
-
A
-
-
A
-
S
-
A
+1 more module
-